Future Health ESG Corp.
FHLTU
NASDAQ Capital Market11.15
USD
-1.85
- -
Future Health ESG Corp.
FHLTU
(NASDAQ Capital Market)
Recent
price
11.15
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Future Health ESG Corp. (NASDAQ: FHLTU) is a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, particularly targeting scale-up stage companies in value-based precision healthcare that leverage data science for improved outcomes, personalization, and cost efficiency while aligning with environmental, social, and governance (ESG) criteria. The company does not have significant independent operations or products; instead, it provides a financial vehicle for public listings through business combinations; its offerings consist solely of securities including units comprising common stock and warrants, redeemable only in connection with an initial business combination or liquidation. Geographically, it operates primarily in the United States, targeting healthcare opportunities with potential for global expansion post-combination. Founded in February 2021 and headquartered at 8 The Green, Suite #12081, Dover, Delaware, the company went public via an initial public offering in 2021 aimed at raising up to $200 million, with nearly all units backed by anchor investors. In recent developments, on February 15, 2024, Future Health entered a Purchase and Sponsor Handover Agreement with Blufire Capital Limited, an Abu Dhabi-based entity serving as the new sponsor, under which Blufire acquired interests in 7,750,000 founder shares and 3,875,000 warrants in exchange for assuming approximately $500,000 in liabilities, including expenses related to pursuing a business combination; a previously announced 2022 merger agreement with Excelera, a healthcare platform, was terminated. Leadership includes CEO and Director Jesvin Kaur and COO Dr. Ulf Henning Richter, with ongoing efforts to identify and complete a business combination amid its extended operations as a SPAC.